Subscribe to Newsletter

Subspecialties

Subspecialties Cornea / Ocular Surface

DMEK Simplified, Deftly

| Marc Muraine

A novel method for preparation of Descemet membrane endothelial keratoplasty (DMEK) grafts is here. It uses a punch but doesn’t lay a finger (or forceps) on the corneal endothelial cells.

Subspecialties Retina

VEGF has Physiolgical as well as Pathological Functions

| Magali Saint-Geniez and Patricia D’Amore

Growing evidence for the key role played by VEGF in the normal adult eye now demands that ophthalmologists give careful consideration to the use of anti-VEGF therapies.

Subspecialties Imaging & Diagnostics

Retinal Visualization of Schizophrenia

| Mark Hillen

OCT imaging visualizes retinal nerve fiber layers and the thickness of the macula; abnormalities in either can predict the stage and duration of schizophrenia.

Subspecialties Cornea / Ocular Surface

Dropper Bother

| Mark Hillen

The UK’s Medicines and Healthcare Products Regulatory Agency (MHRA) issues a safety alert for Cosopt preservative-free single-dose eye drops

Subspecialties Basic & Translational Research

Keeping an Eye on Diabetes

| Mark Hillen

Transplanting pancreatic Islets of Langerhans into the ocular anterior chamber of the eye allows researchers to effectively monitor ?-cell function.

Subspecialties Professional Development

Not All Big Pharma Loves Ophtho

| Mark Hillen

While other pharmaceutical companies are buying into ophthalmology, Pfizer is heading for the hills

Subspecialties Retina

Achieving Consensus on the Treatment of DME with ILUVIEN®

Who should receive ILUVIEN® for the treatment of chronic DME-associated vision impairment

Subspecialties Retina

Treating Macular Edema Following RVO

| Marianne Shahsuvaryan

The last decade has seen some great advances, but there's still room for improvement…

Subspecialties Retina

Predicting Anti-VEGF Treatment Outcomes

| Sebastian Waldstein

Predicting treatment outcomes manages their expectations and improves your care.

Subspecialties Retina

Loss of Traction

| Mark Hillen

If you had VMT or MH and could avoid vitrectomy, you would. Might ocriplasmin let you?

Register to The Ophthalmologist

Register to access our FREE online portfolio, request the magazine in print and manage your preferences.

You will benefit from:
  • Unlimited access to ALL articles
  • News, interviews & opinions from leading industry experts
  • Receive print (and PDF) copies of The Ophthalmologist magazine

Register

Disclaimer

The Ophthalmologist website is intended solely for the eyes of healthcare professionals. Please confirm below: